Literature DB >> 21057161

Fatigue and depressive symptoms associated with chronic viral hepatitis patients. health-related quality of life (HRQOL).

Katerina Karaivazoglou1, Gregoris Iconomou, Christos Triantos, Thomas Hyphantis, Konstantinos Thomopoulos, Maria Lagadinou, Charalambos Gogos, Chryssoula Labropoulou-Karatza, Konstantinos Assimakopoulos.   

Abstract

BACKGROUND AND RATIONALE: It is well established that chronic viral hepatitis (CVH) negatively affects patients . health-related quality of life (HRQOL). The aim of the present study was to assess the extent to which fatigue and depressive symptoms are associated with CVH patients. HRQOL.
METHODS: Eighty-four adult CVH outpatients [45 with hepatitis B virus (HBV) and 39 with hepatitis C virus (HCV) infection] participated in the study. The Short Form-36 Health Survey (SF-36), the Beck Depression Inventory-II (BDI-II) and the Fatigue subscale of the Functional Assessment of Cancer Therapy-Anemia Scale (FACT-F) were used to assess HRQOL, depression and fatigue, respectively.
RESULTS: All aspects of HRQOL perceived by CVH patients were significantly impaired compared to the general population, as a comparison with Greek population-based normative data revealed. HBV patients presented similar HRQOL with HCV patients. Clinical parameters including infection activity, fibrosis stage or inflammation grade, as well as depressive symptoms and fatigue were found to be significantly associated with HRQOL. Multivariate analyses showed that older age (p <0.001) and higher fatigue scores (p <0.001) were the variables most closely associated with the physical HRQOL, whereas higher rates on depressive symptoms (p <0.0005) and fatigue (p <0.020) scales were the variables most closely associated with the mental HRQOL.
CONCLUSIONS: In conclusion, CVH is associated with impaired HRQOL. Fatigue and impaired psychological functioning is associated with diminished HRQOL in CHV, independent of the disease etiology. Consequently, management of fatigue and depressive symptoms should be considered a priority, in order to improve HRQOL in CVH patients.

Entities:  

Mesh:

Year:  2010        PMID: 21057161

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  14 in total

1.  Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study.

Authors:  Jennifer M Loftis; Alexander L Patterson; Clare J Wilhelm; Henry McNett; Benjamin J Morasco; Marilyn Huckans; Timothy Morgan; Shira Saperstein; Aliya Asghar; Peter Hauser
Journal:  J Psychosom Res       Date:  2012-11-21       Impact factor: 3.006

2.  Health-related Quality of Life in Pediatric Patients With Chronic Hepatitis B Living in the United States and Canada.

Authors:  Sarah Jane Schwarzenberg; Simon C Ling; Yona Keich Cloonan; Hsing-Hua S Lin; Donna M Evon; Karen F Murray; Norberto Rodriguez-Baez; Philip Rosenthal; Jeffrey Teckman; Kathleen B Schwarz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-05       Impact factor: 2.839

3.  Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study.

Authors:  Souvik Sarkar; Zhen Jiang; Donna M Evon; Abdus S Wahed; Jay H Hoofnagle
Journal:  J Hepatol       Date:  2012-07-01       Impact factor: 25.083

4.  Psychiatric Morbidity, Fatigue, Stigma and Quality of Life of Patients With Hepatitis B Infection.

Authors:  Rajesh Gupta; Ajit Avasthi; Yogesh K Chawla; Sandeep Grover
Journal:  J Clin Exp Hepatol       Date:  2020-04-13

5.  Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN).

Authors:  Donna M Evon; Abdus S Wahed; Geoffrey Johnson; Mandana Khalili; Mauricio Lisker-Melman; Robert J Fontana; Souvik Sarkar; Bryce B Reeve; Jay H Hoofnagle
Journal:  Dig Dis Sci       Date:  2016-01-30       Impact factor: 3.199

6.  Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort.

Authors:  Joseph S Doyle; Jason Grebely; Tim Spelman; Maryam Alavi; Gail V Matthews; Alexander J Thompson; Gregory J Dore; Margaret E Hellard
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

7.  Health-related quality of life in patients with chronic hepatitis B during antiviral treatment and off-treatment.

Authors:  Xiulan Xue; Shaohang Cai; Hongjie Ou; Caixia Zheng; Xiaolu Wu
Journal:  Patient Prefer Adherence       Date:  2017-01-12       Impact factor: 2.711

8.  Association of Changes in Mood Status and Psychosocial Well-Being with Depression During Interferon-Based Treatment for Hepatitis C.

Authors:  Jung-Seok Choi; Won Kim; Bo Kyung Sohn; Jun-Young Lee; Hee Yeon Jung; Sohee Oh; Sae Kyoung Joo; Hwi Young Kim; Yong Jin Jung
Journal:  Psychiatry Investig       Date:  2017-05-16       Impact factor: 2.505

9.  Risk factors associated with fatigue in chronic hepatitis B patients.

Authors:  Chunxiu Zhong; Junhua Yin; Zhidan Zheng; Shaohang Cai; Yulin Gao
Journal:  Patient Prefer Adherence       Date:  2019-07-04       Impact factor: 2.711

10.  Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B.

Authors:  Maria Buti; Maria Stepanova; Adriana Palom; Mar Riveiro-Barciela; Fatema Nader; Luisa Roade; Rafael Esteban; Zobair Younossi
Journal:  JHEP Rep       Date:  2021-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.